海洋来源塔宾曲霉LWG-42菌株的鉴定及其抗氧化活性化合物的分离

鉴定1株具有抗氧化活性的海洋真菌LWG-42菌株,分离鉴定其抗氧化活性化合物。通过形态学特征和ITS序列分析对菌株LWG-42进行鉴定;利用DPPH自由基清除试验测定抗氧化活性,通过溶剂萃取和柱层析分离LWG-42菌株产生的抗氧化活性化合物;通过化合物的波谱特征鉴定其结构。菌株LWG-42被鉴定为塔宾曲霉(Aspergillus tubingensis);从其发酵产物中分离得到2个化合物aurasperone A和aurasperone B,aurasperone A、B清除DPPH自由基的EC50值分别为0.18和0.11 mg/m L。实验结果为进一步开发这两个化合物在药品、化妆品和食品工业中的应用提供了参考。     

植物内生真菌F4a次级代谢产物的分离鉴定以及降血糖、抗氧化活性的研究

研究植物内生真菌布雷青霉菌（Penicillium brefeldianum） F4a次级代谢产物的提取分离方法、结构鉴定及其降血糖和抗氧化活性。采用液体发酵培养,大孔吸附树脂HP20提取后,经硅胶柱色谱、Sephadex LH-20凝胶柱色谱、ODS反相开放柱色谱和高效液相色谱等手段进行分离,应用核磁共振等技术进行结构鉴定;采用紫外分光光度吸收法进行降血糖和抗氧化活性筛选。结果表明,分离得到6个化合物,分别鉴定为环（L-色氨酸-L-脯氨酸）（1）、3,3′-Methylenebis（4-hydroxy-6-methyl-2H-pyran-2-one）（2）、2-（2′S-Hydroxypropyl）-5-methyl-7-hydroxychromone（3）、染料木素（4）、大豆素（5）和苯酚（6）。化合物1和2具有一定的抗氧化活性,化合物4和5具有较强的抗氧化活性和降血糖活性。化合物2和3为首次从青霉属真菌中分离得到。化合物1和2的ABTS自由基清除活性为首次报道。     

羧甲基茯苓多糖体外抗氧化活性研究

目的：比较不同浓度洗脱液洗脱得到的羧甲基茯苓多糖的抗氧化活性。方法：以茯苓为原料提取茯苓多糖,进行羧甲基取代反应,分离和纯化得到了均一性羧甲基茯苓多糖CMP-1、CMP-2、CMP-3、CMP-4,通过测定还原能力、DPPH自由基清除率、羟基自由基清除率、超氧阴离子自由基清除率比较其体外抗氧化活性。结果：羧甲基茯苓多糖均表现出与浓度正相关的体外抗氧化活性,其中CMP-4具有相对更强的体外抗氧化活性。结论：所得羧甲基茯苓多糖样品具有不同的体外抗氧化能力,随着洗脱液浓度增加,抗氧化活性增强。     

人面果抗氧化活性成分研究

采用DPPH法对人面果树皮和根部不同溶剂提取物进行抗氧化活性研究.结果表明人面果树皮乙酸乙酯提取物的抗氧化活性最强.运用正相和反相硅胶柱层析对人面果树皮乙酸乙酯提取物进行分离纯化,用波谱技术(1D和2D NMR)分析鉴定出2个xanthone类化合物:1,5-dihydroxy-3-methoxyxanthone(1)和2,5-di-hydroxy-1-methoxyxanthone(2),化合物1和2均为首次从该植物中发现.对化合物1和2进行抗氧化活性研究,结果表明化合物1和2显示了一定的抗氧化活性.     

海洋真菌Aspergillus jensenii SS5中化学成分研究

利用多种柱色谱分离技术从海洋真菌Aspergillus jensenii SS5的液体发酵产物中分离获得4个已知化合物,并通过NMR、HR-ESI-MS、X单晶衍射等技术鉴定了它们的结构,分别是epigriseofulvin(1)、sterigmatocystin(2)、brevianamide M(3)、meleagrin(4),其中化合物1～3是首次从曲霉属真菌A.jensenii中分离获得。采用SRB法对分离获得的天然产物进行体外细胞毒性测试,结果表明化合物4对人肺癌A549细胞和人肝癌Bel-7402细胞均有较好抑制作用,化合物2对A549人肺癌细胞株有较好抑制作用。本研究作为海洋真菌A.jensenii SS5的化学成分的补充研究,发现了2个具有较好细胞毒活性的化合物,为曲霉属海洋真菌活性天然产物的开发提供了理论依据。     

旱莲草凝血和溶血活性成分的研究

研究旱莲草中的凝血和溶血活性物质,为旱莲草的开发和利用提供依据。分离到6个化合物,分别为eclalbasaponinⅠ(1)、eclalbasaponinⅣ(2)、eclalbasaponinⅤ(3)、3,4,5-trihydroxy-6-(2-hydroxy-3-(palmitoyloxy)propoxy)-etrahydro-2H-pyran-yl)methanesul-fonic acid(4)、蟛蜞菊内酯(5)和异去甲蟛蜞菊内酯(6),其中化合物4首次从旱莲草中分离到。体外溶血活性实验表明,化合物2~4具有很强溶血活性,在浓度为0.6μg/mL时,对红细胞的溶解率分别达到(93.52±1.56)%、(82.55±2.72)%和(94.99±0.68)%。体外凝血活性研究表明,化合物5、6具有很强的凝血活性,它们既能直接使红细胞凝聚成团,也能通过先使纤维蛋白原转变为纤维蛋白,再通过纤维蛋白使红细胞凝聚成团。     

旱莲草凝血和溶血活性成分的研究北大核心CSCD

研究旱莲草中的凝血和溶血活性物质,为旱莲草的开发和利用提供依据。分离到6个化合物,分别为eclalbasaponinⅠ(1)、eclalbasaponinⅣ(2)、eclalbasaponinⅤ(3)、3,4,5-trihydroxy-6-(2-hydroxy-3-(palmitoyloxy)propoxy)-etrahydro-2H-pyran-yl)methanesul-fonic acid(4)、蟛蜞菊内酯(5)和异去甲蟛蜞菊内酯(6),其中化合物4首次从旱莲草中分离到。体外溶血活性实验表明,化合物2~4具有很强溶血活性,在浓度为0.6μg/mL时,对红细胞的溶解率分别达到(93.52±1.56)%、(82.55±2.72)%和(94.99±0.68)%。体外凝血活性研究表明,化合物5、6具有很强的凝血活性,它们既能直接使红细胞凝聚成团,也能通过先使纤维蛋白原转变为纤维蛋白,再通过纤维蛋白使红细胞凝聚成团。     

水葫芦内生拟枝孢镰刀菌SC1608的次生代谢产物

研究了一株水生植物水葫芦内生拟枝孢镰刀菌Fusarium sporotrichioides SC1608大米发酵物的抗真菌活性次生代谢产物,从中共分离获得6个化合物,经高分辨质谱、三重四极杆质谱和核磁共振谱分析,分别鉴定为4个鞘糖脂类化合物：asperamide B (1)、asperamide D (2)、asperamide E (3)、cerebrosides A (4),以及2个环酯肽类化合物acuminatum A (5)和acuminatum B (6),其中化合物2和化合物3是新的鞘糖脂类化合物。通过滤纸片琼脂扩散法评价了单体化合物的抗真菌活性,证实化合物5和6对柑橘绿霉和玉米小斑病菌均具有较强的体外抑制活性。研究结果初步揭示了F. sporotrichioides SC1608发酵物的抗真菌活性物质基础,丰富了拟枝孢镰刀菌次生代谢产物的化学多样性。     

平颏海蛇的化学成分研究

本文主要研究平颏海蛇干体的化学成分及其抗氧化活性。采用硅胶柱色谱、凝胶柱色谱、重结晶等方法进行分离纯化,从平颏海蛇干体中分离得到7个化合物,根据理化性质和波谱数据鉴定化合物的结构分别为:胆甾醇(1)、5,6β-Epoxysitosteryl oleate(2)、9-Octadecenoic acid(9Z)-,(2R)-2,3-bis[(1-oxooctadecyl)oxy]propyl ester(3)、1-甲基海因(4)、α-棕榈酸甘油酯(5)、鲛肝醇(6)、7α-甲氧基-β-谷甾醇(7)。其中化合物2、3、5、6、7为首次从平颏海蛇中分离得到。采用DPPH自由基清除试验评价化合物的抗氧化活性,结果表明7个化合物几乎无抗氧化活性。     

以Hsp90为靶点的4-(4-羟基-3-甲氧基苯亚甲基)姜黄素抗肿瘤活性研究

合成4-(4-羟基-3-甲氧基苯亚甲基)姜黄素(C085),研究其体外抗肿瘤活性和抑制Hsp90作用。以香草醛和姜黄素为原料,微波条件下Knovenagel缩合反应合成了4-(4-羟基-3-甲氧基苯亚甲基)姜黄素(C085)。以姜黄素为对照,MTT法考察目标化合物对人乳腺癌细胞SKBr3、人慢性粒细胞白血病急变细胞株K562、人急性髓系白血病细胞株HL-60、人肝肿瘤细胞株Hep G2、小鼠黑色素瘤细胞株B-16、人结肠癌细胞株SW480、人胰腺癌细胞株Bxpc-3、人神经母细胞瘤细胞株SH-SY5Y、人胃癌细胞株MGC80-3的抑制活性。对上述细胞株的IC50值依次为0.51、1.26、2.90、0.81、1.77、1.31、8.22、1.93、7.41μmol/L,对多种肿瘤细胞抑制活性明显强于Cur。Western Blot结果表明C085明显下调Hsp90的客户蛋白Her2和AKT的表达水平。分子对接分析也支持C085是Hsp90抑制剂。     

Synthesis and biological evaluation of polyhydroxycurcuminoids

A series of curcumin analogs (1-3, 5a-5t) was synthesized through the condensation of appropriately protected hydroxybenzaldehydes with acetylacetone, followed by deprotection. The antioxidant activity of these analogs was determined by superoxide free radical nitroblue tetrazolium and DPPH free radical scavenging methods and the polyhydroxycurcuminoids (5l-5s) displayed excellent antioxidant activity. These analogs showed cytotoxicity to lymphocytes and promising tumor-reducing activity on Dalton's lymphoma ascites tumor cells.     

Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells

Using concepts of bioisostery a series of curcumin analogs were synthesized: the diketonic system of the compound was elaborated into enaminones, oximes, and the isoxazole heterocycle. The cell growth inhibitory and apoptosis inducing effects of the new analogs were evaluated by in vitro assays in the hepatocellular carcinoma HA22T/VGH cells, as well as in the MCF-7 breast cancer cell line and in its multidrug resistant (MDR) variant MCF-7R. Increased antitumor activity on all cell lines was found with the isoxazole analog and especially with the benzyl oxime derivative; in the HA22T/VGH cell model, the latter compound inhibited constitutive NF-kappaB activation.     

Design, synthesis, synergistic antimicrobial activity and cytotoxicity of 4-aryl substituted 3,4-dihydropyrimidinones of curcumin

3,4-Dihydropyrimidinones of curcumin were synthesized in excellent yield by multi-component one-pot condensation of curcumin, substituted aromatic aldehydes and urea/thiourea under solvent free conditions using SnCl(2)·2H(2)O catalyst. All the synthesized compounds have been characterized by IR, (1)H NMR, (13)C NMR, Mass spectra as well as elemental analyses. The synthesized compounds 4a-n were evaluated for their synergistic antimicrobial (antibacterial and antifungal) activity against bacteria and fungi. Zone of inhibition was measured by adopting disc diffusion method. In vitro minimum inhibitory concentrations were measured using broth microdilution and food poisoning method. In addition to this in vitro cytotoxicity of synthesized compounds against three human cancer lines Hep-G2, HCT-116 and QG-56 were also evaluated. Most of the compounds showed interesting antimicrobial and cytotoxic activity as compared to curcumin, that is, the compounds derived from 2-hydroxy benzaldehyde, 4-hydroxy benzaldehyde and 4-hydroxy-3-methoxy benzaldehyde showed the highest biological activity as compared to other compounds.     

Antioxidation and tyrosinase inhibition of polyphenolic curcumin analogs

A series of polyphenolic curcumin analogs were synthesized and their inhibitory effects on mushroom tyrosinase and the inhibition of 1,1-diphenyl-2-picryl-hydrazyl (DPPH) free radical formation were evaluated. The results indictated that the analogs possessing m-diphenols and o-diphenols exhibited more potent inhibitory activity on tyrosinase than reference compound rojic acid, and that the analogs with o-diphenols exhibited more potent inhibitory activity of DPPH free-radical formation than reference compound vitamin C. The inhibition kinetics, analyzed by Lineweaver-Burk plots, revealed that compounds B(2) and C(2) bearing o-diphenols were non-competitive inhibitors, while compounds B(11) and C(11) bearing m-diphenols were competitive inhibitors. In particular, representative compounds C(2) and B(11) showed no side effects at a dose of 2,000 mg/kg in a preliminary evaluation of acute toxicity in mice. These results suggest that such polyphenolic curcumin analogs might serve as lead compounds for further design of new potential tyrosinase inhibitors.     

Quinoline Based Monocarbonyl Curcumin Analogs as Potential Antifungal and Antioxidant Agents: Synthesis,Bioevaluation and Molecular Docking Study

In search for new fungicidal and free radical scavenging agents, we synthesized a focused library of 2‐chloroquinoline based monocarbonyl analogs of curcumin (MACs). The synthesized MACs were evaluated for in vitro antifungal and antioxidant activity. The antifungal activity was evaluated against five different fungal strains such as Candida albicans, Fusarium oxysporum, Aspergillus flavus, Aspergillus niger, and Cryptococcus neoformans, respectively. Most of the synthesized MACs displayed promising antifungal activity compared to the standard drug Miconazole. Furthermore, molecular docking study on a crucial fungal enzyme sterol 14α‐demethylase (CYP51) could provide insight into the plausible mechanism of antifungal activity. MACs were also screened for in vitro radical scavenging activity using butylated hydroxytoluene (BHT) as a standard. Almost all MACs exhibited better antioxidant activity compared to BHT.     

Antitumor agents 290. Design, synthesis, and biological evaluation of new LNCaP and PC-3 cytotoxic curcumin analogs conjugated with anti-androgens

In our continuing study of curcumin analogs as potential anti-prostate cancer drug candidates, 15 new curcumin analogs were designed, synthesized and evaluated for cytotoxicity against two human prostate cancer cell lines, androgen-dependent LNCaP and androgen-independent PC-3. Twelve analogs (5-12, 15, 16, 19, and 20) are conjugates of curcumin (1) or methyl curcumin (2) with a flutamide- or bicalutamide-like moiety. Two compounds (22 and 23) are C4-mono- and difluoro-substituted analogs of dimethyl curcumin (DMC, 21). Among the newly synthesized conjugates compound 15, a conjugate of 2 with a partial bicalutamide moiety, was more potent than bicalutamide alone and essentially equipotent with 1 and 2 against both prostate tumor cell lines with IC(50) values of 41.8 μM (for LNCaP) and 39.1 μM (for PC-3). A cell morphology study revealed that the cytotoxicity of curcumin analogs or curcumin-anti-androgen conjugates detected from both prostate cancer cell lines might be due to the suppression of pseudopodia formation. A molecular intrinsic fluorescence experiment showed that 1 accumulated mainly in the nuclei, while conjugate 6 was distributed in the cytosol. At the tested conditions, anti-androgens suppressed pseudopodia formation in PC-3 cells, but not in LNCaP cells. The evidence suggests that distinguishable target proteins are involved, resulting in the different outcomes toward pseudopodia suppression.     

Novel curcumin analogs targeting TNF-induced NF-kappaB activation and proliferation in human leukemic KBM-5 cells

Novel curcumin analogs were synthesized using Knoevenagel condensation to convert enolic diketones of curcumin into non-enolizable ones and Schiff bases were prepared using a bioactive thiosemicarbazide pharmacophore. Copper(II) conjugates of all synthesized ligands were prepared and structurally characterized as well as evaluated for their potential of inhibiting TNF-induced NF-kappaB activation and proliferation in human leukemic KBM-5 cells wherein compound 13 was found to be more potent than curcumin. Compounds were further examined on other tumor cell lines such as Jurkat, H1299, and MM1, respectively.     

Recent Updates in Curcumin Pyrazole and Isoxazole Derivatives: Synthesis and Biological Application

Curcumin is an admired, plant‐derived compound that has been extensively investigated for diverse range of biological activities, but the use of this polyphenol is limited due to its instability. Chemical modifications in curcumin are reported to seize this limitation; such efforts are intensively performed to discover molecules with similar but improved stability and better properties. Focal points of these reviews are synthesis of stable pyrazole and isoxazole analogs of curcumin and application in various biological systems. This review aims to emphasize the latest evidence of curcumin pyrazole analogs as a privileged scaffold in medicinal chemistry. Manifold features of curcumin pyrazole analogs will be summarized herein, including the synthesis of novel curcumin pyrazole analogs and the evaluation of their biological properties. This review is expected to be a complete, trustworthy and critical review of the curcumin pyrazole analogs template to the medicinal chemistry community.     

Structure-activity relationship study of arylsulfonylimidazolidinones as anticancer agents

In an effort to find novel N-arylsulfonylimidazolidinones as highly potent anticancer agent, the structure-activity relationship of ethyl 2-methyl-4-(2-oxo-4-phenylimidazolidin-1-ylsulfonyl)phenylcarbamate was explored through synthesis and evaluation of in vitro cytotoxicity of its analogs against HCT116, A549 and NCL-H460 cancer cell lines. Among the synthesized derivatives, the carbamate analogs (4a-f and 4k-p) exhibited superior cytotoxicity to doxorubicin for all cancer cell lines. The SAR studies of these derivatives confirm that the intact 4-phenyl-l-benzenesulfonylimidazolidinone has a pivotal role as a basic pharmacophore and hydrophobic substitutions only at 2-position of 1-aminobenzenesulfonyl moiety are beneficial for the enhancement of the activity.